News
-
Treating liver disease in people living with HIV
The CTNPT 024 team investigated whether vitamin E could be a treatment option for NASH, a type of liver disease that is more common among people living with HIV
Resources
Our Resource Library is a place to share documents, videos, and training resources about HIV and STBBI research and related topics.
There are no results message
Studies
The CTN+ supports clinical trials, implementation science projects, and non-interventional research of the highest scientific and ethical standards.
-
CTN 326: LIVEHIV Cohort Plus
The role of fatty liver in the epidemic of advanced chronic liver disease among people living with HIV
-
CTNPT 035: Vitamin D insufficiency and NAFLD in persons living with HIV
Association of vitamin D insufficiency with non-alcoholic fatty liver disease in HIV mono-infected patients
-
CTNPT 014: Kaletra®/Celsentri® combination therapy for HIV in the setting of HCV
An observational study of Kaletra®/Celsentri® combination therapy
-
CTN 260: Raltegravir switch study
A randomized prospective open-label study of switching to raltegravir based antiretroviral therapy (ART) compared to maintaining ritonavir boosted protease inhibitor-based ART on liver fibrosis progression in HIV-HCV co-infected individuals
-
CTN 222: Canadian co-infection cohort
A prospective clinical cohort of HIV and hepatitis C virus co-infected patients
-
CTN 289: E/C/F/TAF switch with ledipasivir-sofosbuvir therapy
Evaluation of E/C/F/TAF switch followed by ledipasivir-sofosbuvir antiviral HCV therapy in HIV-HCV co-infection
Publications
Our researchers and trainees have produced hundreds of peer-reviewed publications in a wide range of HIV- and STBBI-related areas.